Alnylam Pharmaceuticals
ALNY
#728
Rank
$34.24 B
Marketcap
$255.96
Share price
2.55%
Change (1 day)
-42.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company